South Korea Cell And Gene Therapy CDMO Market (2025-2031) | Outlook, Competitive Landscape, Companies, Trends, Value, Size & Revenue, Growth, Industry, Analysis, Forecast, Share, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F

3.3 South Korea Cell And Gene Therapy CDMO Market - Industry Life Cycle

3.4 South Korea Cell And Gene Therapy CDMO Market - Porter's Five Forces

3.5 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.6 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in RD for cell and gene therapy in South Korea

4.2.2 Government support and favorable regulations for cell and gene therapy development

4.2.3 Growing demand for personalized medicine and targeted therapies in the healthcare sector

4.3 Market Restraints

4.3.1 High cost associated with cell and gene therapy manufacturing and development

4.3.2 Limited skilled workforce and expertise in cell and gene therapy technology

4.3.3 Stringent regulatory requirements and compliance standards for cell and gene therapy production

6.1 South Korea Cell And Gene Therapy CDMO Market, By Phase

6.1.1 Overview and Analysis

6.1.2 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F

6.1.3 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F

6.1.4 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.2 South Korea Cell And Gene Therapy CDMO Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.3 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F

6.2.4 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.3 South Korea Cell And Gene Therapy CDMO Market, By Indication

6.3.1 Overview and Analysis

6.3.2 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.4 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F

6.3.5 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F

6.3.6 South Korea Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F

7.1 South Korea Cell And Gene Therapy CDMO Market Export to Major Countries

7.2 South Korea Cell And Gene Therapy CDMO Market Imports from Major Countries

8.1 Number of partnerships and collaborations between South Korean CDMOs and international biopharmaceutical companies

8.2 Rate of adoption of advanced manufacturing technologies in cell and gene therapy production

8.3 Number of clinical trials utilizing cell and gene therapies conducted in South Korea

9.1 South Korea Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F

9.2 South Korea Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 South Korea Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 South Korea Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024

10.2 South Korea Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters